Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Reis Neto, Edgard Torres, Kakehasi, Adriana Maria, de Medeiros Pinheiro, Marcelo, Ferreira, Gilda Aparecida, Marques, Cláudia Diniz Lopes, da Mota, Licia Maria Henrique, dos Santos Paiva, Eduardo, Pileggi, Gecilmara Cristina Salviato, Sato, Emília Inoue, Reis, Ana Paula Monteiro Gomides, Xavier, Ricardo Machado, Provenza, José Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282202/
https://www.ncbi.nlm.nih.gov/pubmed/32517786
http://dx.doi.org/10.1186/s42358-020-00134-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282202/
https://www.ncbi.nlm.nih.gov/pubmed/32517786
http://dx.doi.org/10.1186/s42358-020-00134-8

Ejemplares similares